Skip to main content

Table 5 Treatment trend overtime according to the prescribed anticoagulation

From: Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study

   

T12h

T24h

T48h

T72h

No-Anticoagulation (n = 4)

Still running at that time point

 

2 (50%)

0

  

Withdrawn before that time point

 

2 (50%)

2 (50%)

  

Patient death

1 (50%)

   

Circuit clotting

1 (50%)

1 (50%)

  

Voluntary interruption

 

1 (50%)

  
 

Max circuit life (72hrs)

0 (0%)

Heparin (n = 6)

Still running at that time point

 

4 (66.7%)

3 (50%)

2 (33.3%)

1 (16.7%)

Withdrawn before that time point

 

2 (33.3%))

1 (16.7%)

2 (33.3%)

 

Patient death

1 (50%)

1 (100%)

  

Circuit clotting

    

Voluntary interruption

1(50%)

 

2 (100%)

 
 

Max circuit life (72hrs)

1 (16.7%)

Citrate (n = 27)

Still running at that time point

 

22 (81.5%)

17 (63%)

13 (48.1 %)

6 (22.2%)

Withdrawn before that time point

 

5 (18.5%)

5 (18.5%)

4 (14.8%)

7 (25.9%)

Patient death

2 (40%)

1 (20%)

1 (25%)

3 (42.9%)

Circuit clotting

2 (40%)

3 (60%)

1 (25%)

 

Voluntary interruption

1 (20%)

1 (20%)

2 (50%)

4 (57.1%)

 

Max circuit life (72hrs)

6 (22.2%)